Table 1. Characteristics of the included 10 studies.

No	Study	Year	Nation	TP	FP	FN	TN	No. of Tumors	Study Design	Magnetic field strength	Dose of Gd-EOB-DTPA	Patients
												Enrollment	Ratio of Men to Women	Child-Pugh classification (A/B/C)
1	Bashir [9]	2013	American	64	14	6	41	125	retro	1.5/3.0T	10ml	consecutive cirrhosis patients,22mo (9/08–6/10)	57/43	ND
2	Blondin [11]	2011	Germany	37	1	4	5	47	retro	1.5T	10ml	consecutive patients,26mo (1/07–3/09)	25/8	22/9/2
3	Filippone [12]	2010	Italy	36	1	3	14	54	retro	1.5T	0.025mmol/Kg	cirrhosis patients,31mo (9/07–4/10)	27/7	21/8/5
4	Ooka [12]	2012	Japan	82	10	5	344	441	retro	1.5T	0.025mmol/Kg	consecutive patients,16mo (2/08–6/09)	40/14	46/8/0
5	Baek [13]	2010	Korea	63	4	10	55	132	retro	3.0T	0.025mmol/Kg	consecutive patients,13mo(5/08–6/09)	43/8	42/7/2
6	Akai [14]	2011	Japan	46	2	6	52	106	pro	1.5T	0.025mmol/Kg	consecutive patients,8mo (6/08–2/09)	27/7	ND
7	Park [15]	2012	Korea	147	2	32	142	323	retro	3.0T	0.025mmol/Kg	consecutive cirrhosis patients,13mo (5/09–6/10)	185/75	230/28/2
8	Sano [16]	2011	Japan	88	6	3	155	252	retro	1.5T	0.025mmol/Kg	consecutive patients,22mo (1/08–11/09)	47/17	54/10/0
9	Golfieri [17]	2011	Italy	172	2	1	40	215	pro	1.5T	0.025mmol/Kg	consecutive cirrhosis patients,13mo (5/08–10/09)	127/0	ND
10	Haradome [19]	2011	Japan	52	3	8	36	99	retro	1.5T	0.025mmol/Kg	consecutive patients,17mo (1/08–6/09)	60/15	48/5/22

TP, true-positive; FP, false-positive; TN, true-negative; FN, false-negative; ND, no data.